Amneal Pharmaceuticals, Inc. AMRX PP&E Sale Proceeds
PP&E Sale Proceeds at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s pp&e sale proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s PP&E sale proceeds?
- Amneal Pharmaceuticals, Inc. (AMRX) reported PP&E sale proceeds of $0 in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s PP&E sale proceeds changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s PP&E sale proceeds decreased by 100.0% year-over-year, from $524K to $0.
- What does PP&E sale proceeds mean?
- Cash received from selling property, plant, and equipment no longer needed for operations.